These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15380211)

  • 21. Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases.
    Caselli E; Powers RA; Blasczcak LC; Wu CY; Prati F; Shoichet BK
    Chem Biol; 2001 Jan; 8(1):17-31. PubMed ID: 11182316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors.
    Xia Y; Cao K; Zhou Y; Alley MR; Rock F; Mohan M; Meewan M; Baker SJ; Lux S; Ding CZ; Jia G; Kully M; Plattner JJ
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2533-6. PubMed ID: 21392987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of class D beta-lactamases by diaroyl phosphates.
    Majumdar S; Adediran SA; Nukaga M; Pratt RF
    Biochemistry; 2005 Dec; 44(49):16121-9. PubMed ID: 16331972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the longevity of the beta-lactam antibiotics and of antibiotic/beta-lactamase inhibitor combinations.
    Buynak JD
    Biochem Pharmacol; 2006 Mar; 71(7):930-40. PubMed ID: 16359643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and beta-lactamase reactivity of alpha-substituted phenaceturates.
    Adediran SA; Cabaret D; Flavell RR; Sammons JA; Wakselman M; Pratt RF
    Bioorg Med Chem; 2006 Oct; 14(20):7023-33. PubMed ID: 16806948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of beta-lactamases by monocyclic acyl phosph(on)ates.
    Kaur K; Adediran SA; Lan MJ; Pratt RF
    Biochemistry; 2003 Feb; 42(6):1529-36. PubMed ID: 12578365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inverse acyl phosph(on)ates: substrates or inhibitors of beta-lactam-recognizing enzymes?
    Morrison MJ; Li N; Pratt RF
    Bioorg Chem; 2001 Oct; 29(5):271-81. PubMed ID: 16256697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of beta-lactamases on the development of novel antimicrobial agents.
    Bush K
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1284-90. PubMed ID: 12498001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of AmpC beta-lactamase in Enterobacter cloacae isolated from retail ground beef, cattle farm and processing facilities.
    Kim SH; Wei CI
    J Appl Microbiol; 2007 Aug; 103(2):400-8. PubMed ID: 17650200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed quantum mechanical/molecular mechanical (QM/MM) study of the deacylation reaction in a penicillin binding protein (PBP) versus in a class C beta-lactamase.
    Gherman BF; Goldberg SD; Cornish VW; Friesner RA
    J Am Chem Soc; 2004 Jun; 126(24):7652-64. PubMed ID: 15198613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of Sepharose-bound beta-lactamase from Enterobacter cloacae.
    Pastorino AM; Dalzoppo D; Fontana A
    J Appl Biochem; 1985 Apr; 7(2):93-7. PubMed ID: 3877044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metallo-beta-lactamase inhibitors: promise for the future?
    Toney JH; Moloughney JG
    Curr Opin Investig Drugs; 2004 Aug; 5(8):823-6. PubMed ID: 15600238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why clinically used tazobactam and sulbactam are poor inhibitors of OXA-10 beta-lactamase: Raman crystallographic evidence.
    Totir MA; Cha J; Ishiwata A; Wang B; Sheri A; Anderson VE; Buynak J; Mobashery S; Carey PR
    Biochemistry; 2008 Apr; 47(13):4094-101. PubMed ID: 18324783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-(phenylacetyl)glycyl-D-aziridine-2-carboxylate, an acyclic amide substrate of beta-lactamases: importance of the shape of the substrate in beta-lactamase evolution.
    Murphy BP; Pratt RF
    Biochemistry; 1991 Apr; 30(15):3640-9. PubMed ID: 2015222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assays for beta-lactamase activity and inhibition.
    Viswanatha T; Marrone L; Goodfellow V; Dmitrienko GI
    Methods Mol Med; 2008; 142():239-60. PubMed ID: 18437319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptidase activity of beta-lactamases.
    Rhazi N; Galleni M; Page MI; Frère JM
    Biochem J; 1999 Jul; 341 ( Pt 2)(Pt 2):409-13. PubMed ID: 10393100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reactions of derivatives of beta-lactam antibiotics with non-antibacterial biological activity].
    Gunda T
    Acta Pharm Hung; 2002; 72(4):223-30. PubMed ID: 12812042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substituted aryl malonamates as new serine beta-lactamase substrates: structure-activity studies.
    Adediran SA; Cabaret D; Lohier JF; Wakselman M; Pratt RF
    Bioorg Med Chem; 2010 Jan; 18(1):282-91. PubMed ID: 19932622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.